Htr2c gene polymorphisms and the metabolic syndrome in patients with schizophrenia / Hans Mulder en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 1 (Febrero) . - pp. 16-20 Título : Htr2c gene polymorphisms and the metabolic syndrome in patients with schizophrenia : A replication study Tipo de documento: texto impreso Autores: Hans Mulder, Autor ; Dan Cohen, Autor ; Hans Scheffer, Autor Fecha de publicación: 2022 Artículo en la página: pp. 16-20 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: HTR2C, Antipsicóticos, Síndrome metabólico, Esquizofrenia Resumen: In a previous study, we found an association between 5-hydroxytryptamine (serotonin) receptor 2C (HTR2C) polymorphisms and the occurrence of the metabolic syndrome in patients using antipsychotics. In the current study, we set out to replicate our findings in another sample of patients and to explore in a pooled analysis of both samples the influence of the effect of individual antipsychotics. Link: ./index.php?lvl=notice_display&id=29523 [artículo] Htr2c gene polymorphisms and the metabolic syndrome in patients with schizophrenia : A replication study [texto impreso] / Hans Mulder, Autor ; Dan Cohen, Autor ; Hans Scheffer, Autor . - 2022 . - pp. 16-20. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 1 (Febrero) . - pp. 16-20 Palabras clave: HTR2C, Antipsicóticos, Síndrome metabólico, Esquizofrenia Resumen: In a previous study, we found an association between 5-hydroxytryptamine (serotonin) receptor 2C (HTR2C) polymorphisms and the occurrence of the metabolic syndrome in patients using antipsychotics. In the current study, we set out to replicate our findings in another sample of patients and to explore in a pooled analysis of both samples the influence of the effect of individual antipsychotics. Link: ./index.php?lvl=notice_display&id=29523

Medication discrepancies at outpatient departments for mood and anxiety disorders in the netherlands / Mirjam Simoons en The Journal of Clinical Psychiatry, Año 2016 - Vol.77 - No.11 (Noviembre)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.11 (Noviembre) . - pp. 1511–1518 Título : Medication discrepancies at outpatient departments for mood and anxiety disorders in the netherlands : Risks and clinical relevance Tipo de documento: texto impreso Autores: Mirjam Simoons, Autor ; Hans Mulder, Autor ; Arne J. Risselada, Autor Fecha de publicación: 2020 Artículo en la página: pp. 1511–1518 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agentes contra la ansiedad, Antidepresivos, Trastornos de ansiedad, Trastornos del humor - farmacoterapia. Resumen: To identify discrepancies between actual drug use by outpatients with mood and anxiety disorders and medication overviews from health care providers as well as to investigate the clinical relevance of those discrepancies. Link: ./index.php?lvl=notice_display&id=21785 [artículo] Medication discrepancies at outpatient departments for mood and anxiety disorders in the netherlands : Risks and clinical relevance [texto impreso] / Mirjam Simoons, Autor ; Hans Mulder, Autor ; Arne J. Risselada, Autor . - 2020 . - pp. 1511–1518. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.11 (Noviembre) . - pp. 1511–1518 Palabras clave: Agentes contra la ansiedad, Antidepresivos, Trastornos de ansiedad, Trastornos del humor - farmacoterapia. Resumen: To identify discrepancies between actual drug use by outpatients with mood and anxiety disorders and medication overviews from health care providers as well as to investigate the clinical relevance of those discrepancies. Link: ./index.php?lvl=notice_display&id=21785

Polymorphisms of the lep- and lepr gene and obesity in patients using antipsychotic medication / Jochem G. Gregoor en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 1 (Febrero) . - pp. 21-25 Título : Polymorphisms of the lep- and lepr gene and obesity in patients using antipsychotic medication Tipo de documento: texto impreso Autores: Jochem G. Gregoor, Autor ; Jan van der Weide, Autor ; Hans Mulder, Autor Fecha de publicación: 2022 Artículo en la página: pp. 21-25 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Obesidad, Aumento de peso, Farmacogenética, Polimorfismo, Leptina Resumen: Weight gain is one of the most serious adverse effects of atypical antipsychotic agents. Genetic factors influence the risk of an individual to gain weight. The objective of our study was to determine whether the LEPR Q223R polymorphism and the LEP promoter 2548G/A polymorphism are associated with obesity in a group of male and female patients using atypical antipsychotic drugs. Link: ./index.php?lvl=notice_display&id=29524 [artículo] Polymorphisms of the lep- and lepr gene and obesity in patients using antipsychotic medication [texto impreso] / Jochem G. Gregoor, Autor ; Jan van der Weide, Autor ; Hans Mulder, Autor . - 2022 . - pp. 21-25. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 1 (Febrero) . - pp. 21-25 Palabras clave: Antipsicóticos, Obesidad, Aumento de peso, Farmacogenética, Polimorfismo, Leptina Resumen: Weight gain is one of the most serious adverse effects of atypical antipsychotic agents. Genetic factors influence the risk of an individual to gain weight. The objective of our study was to determine whether the LEPR Q223R polymorphism and the LEP promoter 2548G/A polymorphism are associated with obesity in a group of male and female patients using atypical antipsychotic drugs. Link: ./index.php?lvl=notice_display&id=29524

---

1 (1 - 3 / 3)